Published Feb 19, 2007
Richard Epstein on Property Rights and Drug Patents
Russ Roberts and Richard Epstein delve into the complex interplay of pharmaceutical economics, patent rights, and FDA regulations, highlighting how these factors impact drug innovation, market dynamics, and consumer affordability. Epstein critiques regulatory frameworks, emphasizing the crucial balance between incentivizing innovation and providing affordable access to life-saving medications.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
Richard Epstein on Regulation
Answers 383 questions
Robin Feldman on Drug Patents, Generics, and Drug Wars
Answers 383 questionsRichard Epstein on the Rule of Law
Answers 383 questionsRichard Epstein on Property Rights, Zoning and Kelo
Answers 383 questionsRichard Epstein on the Constitution
Answers 383 questionsRobin Feldman on Drugs, Money, and Secret Handshakes
Answers 383 questions
Michele Boldrin on Intellectual Property
Answers 383 questionsRichard Epstein on the Economics of Organ Donation
Answers 383 questionsRichard Epstein on Classical Liberalism, Libertarianism, and Lochner
Answers 383 questionsVinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Answers 383 questionsRichard Epstein on Cruises, First-Class Travel, and Inequality
Answers 383 questionsRichard Epstein on Happiness, Inequality, and Envy
Answers 383 questions
Alex Tabarrok on Innovation
Answers 383 questionsRichard Epstein on Legislators vs. Wal-Mart
Answers 383 questions
Casey Mulligan on Vaccines, the Pandemic, and the FDA
Answers 383 questions